Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Douglas Scientific, LGC Distribution Agreement

Published: Monday, August 11, 2014
Last Updated: Monday, August 11, 2014
Bookmark and Share
Companies have formalized an exclusive distribution agreement for the sale of Douglas Scientific’s innovative Array Tape® Platform.

Under the terms of this agreement LGC will represent and distribute the existing and future Array Tape laboratory automation platforms in Europe, Middle East and Africa. 

The combination of disruptive lab automation and KASP™ genotyping assays and reagents, creates a catalyst, driving laboratory productivity and the efficiencies required in genotyping laboratories today. 

“This relationship is more than extending the reach of our individual product offerings. It’s about the alignment of two compelling missions. Douglas Scientific exists to make the world a better place with laboratory innovation and LGC is committed to science for a safer world,” says Darren Cook, Executive Vice President of Business Development and Strategy, Douglas Scientific, “If our combined solution results in more food for a growing population, a safer food supply and environment, and faster and less costly diagnostics, then we’ve achieved something much more powerful than we could have independently.” 

Giulio Cerroni, Managing Director, Genomics, LGC, comments, “LGC has a great history of working with many diverse companies, consortiums and researchers globally, to increase the understanding of genetic markers in medical research and plant science. Through this new agreement, LGC and Douglas Scientific will further enhance our combined efforts to enable scientists worldwide to reach their goals of feeding the world, curing the world and protecting the world.” 

The Array Tape Platform is comprised of Nexar® liquid handling and assay processing system, Soellex® PCR waterbath, Araya® detection, and the Intellics™ Software Suite. The instrumentation enables end-point reactions in Array Tape with small volume reactions (1.6 μL). Array Tape is a continuous polymer strip, serially embossed with reaction wells in customized volumes and formats. The platform is highly compatible with LGC’s KASP genotyping assays and reagents. 

LGC’s high-throughput genomics services, offered from UK, US and German laboratories, utilize their own proprietary sbeadex™ DNA extraction chemistry and laboratory-validated genotyping assays, while also taking advantage of their patented fluorescence-based competitive allele-specific PCR (polymerase chain reaction) technique, KASP. 

KASP chemistry is an enabling technology that is utilized to genotype known polymorphisms such as SNPS and InDels in the targeted DNA. 

LGC scientists have contributed significantly to the development of new genotyping technologies, making affordable projects accessible to a broad range of customers, independent of project size. To date, they have extracted DNA from over 10 million samples, as well as processed over 1 billion PCR reactions. 

The combined technologies offered via this relationship will provide a fast, cost effective, and robust solution for high-throughput genetic analysis that significantly simplifies sample preparation, decreases cost per sample, and increases sample throughput. Together, Douglas Scientific and LGC’s Genomics Division will work with customers in the pharmaceuticals, agricultural biotechnology, food, environment, government, academic, security and sports sectors to achieve excellence in investigative, diagnostic and measurement science and to provide a disruptive and complete solution for any high-throughput laboratories currently using PCR technologies.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

EnviroLogix™ Signs Collaborative Agreement with Douglas Scientific™
The agreement will see the companies develop and optimize solutions for high throughput real time and endpoint nucleic acid analysis.
Tuesday, July 24, 2012
Scientific News
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
JPK Instruments reports on the use of their NanoWizard® AFM system at the Instituto de Medicina Molecular at the University of Lisbon.
$1M NIH Grant to Refine PCR Based Cancer Test
Researchers at Cornell University, Weill Cornell Medicine, the University of California, San Francisco, and the Infectious Diseases Institute in Kampala, Uganda, recieve a four-year, $1 million grant to hone technology for a quick, in-the-field diagnosis of Kaposi's sarcoma — a cancer frequently related to HIV infections.
Zika Reference Strain Sequenced
An international research team has sequenced a strain of Zika for use as a WHO reference strain.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!